HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Real-World Effectiveness of Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
SBRT With DIBH for HCC After TACE and Lipiodol Marking
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Efficacy of TACE With Endoscopic Therapy for Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
18F-DCFPyL PET/CT in Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
- Status
- COMPLETED
- Phase
- PHASE2
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Hepatic Arterial Infusion Combined With Lenvatinib and Camrelizumab for Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Observational Study of Factors Predicting Therapeutic Effects and Clinical Prognosis After HAIC for Locally Advanced HCC
- Status
- RECRUITING
- Phase
- N/A
Tislelizumab in the Systematic Treatment of Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection
- Status
- UNKNOWN
- Phase
- PHASE2
TT-4 As a Single Agent in Subjects with Advanced Selected Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world Study
- Status
- COMPLETED
- Phase
- N/A
PD-1 Antibody and Lenvatinib Plus TACE on Downstaging BCLC B/C HCC
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
The Efficacy of Hepatic Arterial Infusion Chemotherapy (HAIC) Combine Lenvatinib and Durvalumab (HILL) in Advanced Hepatocellular Carcinoma (HCC)
- Status
- UNKNOWN
- Phase
- PHASE2
Fusion Imaging Contrast-enhanced Ultrasound LI-RADS
- Status
- UNKNOWN
- Phase
- NA